Effects of KISS1 Structural Polymorphism on the Risk of Polycystic Ovary Syndrome and Reproductive Hormones in Iraqi Women Taking Metformin

    Ali Hakem Kadhem, Ashraf Gholizadeh, Mohammad Khalaj‐Kondori
    Studysummary This study found that metformin increased follicle-stimulating hormone levels and decreased kisspeptin concentrations in Iraqi women with polycystic ovary syndrome, with gene variations potentially influencing treatment response.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.sagepub.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Hirsutism, Normal Androgens, and Diagnosis of PCOS Diagnostics · 2022
    2. A Systematic Review of the Effect of Platelet-Rich Plasma on Androgenetic Alopecia in Women Dermatologic Therapy · 2020
    3. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies Clinical medicine insights · 2019

    Related research 2

    1. Metformin Therapy for the Reproductive and Metabolic Consequences of Polycystic Ovary Syndrome Diabetologia · 2017
    2. Metformin: An Old Medication of New Fashion: Evolving New Molecular Mechanisms and Clinical Implications in Polycystic Ovary Syndrome European journal of endocrinology · 2009